NYU Dentistry, LLS to provide dental care for veterans with blood cancer

Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center

Jonathan M. Gerber was named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center.

July 26, 2024

Cell donor’s socioeconomic status shapes cancer treatment outcomes

The socioeconomic status of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation, according to a new study led by researchers at the University of Minnesota Medical School.

July 19, 2024

Vol.50 No.29

Clinical Roundup

AI tool helps to diagnose and predict severity of lung cancers

A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence can accurately diagnose cases of adenocarcinoma, the most common form of lung cancer, a study published June 11 in Nature Communications shows.

June 14, 2024

Vol.50 No.24

Drugs & Targets

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy for patients in Estonia.

May 31, 2024

Vol.50 No.22

In Brief

Jonathan Yang named director of clinical research at NYU Brain and Spine Tumor Center

Jonathan T. Yang has joined NYU Langone Health’s Perlmutter Cancer Center as director of clinical research at its Brain and Spine Tumor Center.

May 24, 2024

Vol.50 No.21

Clinical Roundup

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.

May 24, 2024

Vol.50 No.21

NYU Dentistry, LLS to provide dental care for veterans with blood cancer

YOU MAY BE INTERESTED IN

Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center

Cell donor’s socioeconomic status shapes cancer treatment outcomes

AI tool helps to diagnose and predict severity of lung cancers

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

Jonathan Yang named director of clinical research at NYU Brain and Spine Tumor Center

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

Renew today!

Subscriber content

Login